Bioelectronic medicine shows potential to treat pulmonary hypertension - PRNewswire

Bioelectronic medicine shows potential to treat pulmonary hypertension - PRNewswire

Bioelectronic medicine shows potential to treat pulmonary hypertension - PRNewswire

Posted: 09 Dec 2019 12:00 AM PST

PAH, a disease of the pulmonary vessels that causes heart failure and death, is a form of a broader condition known as pulmonary hypertension or high blood pressure in the vessels of the lungs. PAH is caused by narrowing of the arteries that carry blood from the heart to the lungs for oxygenation and often leads to heart failure and death.

Current treatments for PAH include several classes of drugs that target signaling pathways in vascular biology and cardiovascular physiology. They can have severe unwanted side effects, and the treatment does not typically stop the progression of the disease.

Bioelectronic medicine is an emerging approach to treat and diagnose disease and injury using device technology to modulate the electrical activity within the body's nervous system. In particular, vagus nerve stimulation (VNS) has been studied for the treatment of cardiovascular disorders like arrhythmias, heart failure and arterial hypertension and could be used to treat PAH.

"VNS has proven, positive effects on suppressing inflammation and restoring homeostatic autonomic balance within the body," said Dr. Zanos. "There is a need to explore bioelectronic medicine as a way to normalize the function of the heart and the pulmonary vessels to provide treatment alternatives for PAH and help thousands of patients with this disease."

Stimulating the vagus nerve produces pulmonary vasodilation, or widening of blood vessels in the lung, suppresses inflammation and restores autonomic balance, all of them being desirable effects in patients with PAH. Dr. Zanos explains that physiological studies of preclinical animal models of PAH point to potential therapeutic effects of VNS and warrant further investigations.

"Knowing that current PAH pharmacological treatments have adverse side effects and fail to treat the disease itself, Dr. Zanos highlights the need to continue producing knowledge about bioelectronic medicine's potential to treat PAH," said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes.

About the Feinstein Institutes
 The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York. Home to 50 research labs, 2,500 clinical research studies and 4,000 researchers and staff, the Feinstein Institutes is raising the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We're making breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we're producing knowledge to cure disease, visit feinstein.northwell.edu.

SOURCE The Feinstein Institutes for Medical Research

Related Links

https://feinstein.northwell.edu

Comments

Post a Comment

Popular posts from this blog

Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor

Image
Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Epoprostenol Via High-Flow Nasal Cannula Improves Severe Hypoxemia in PH - Pulmonology Advisor Posted: 11 Jul 2019 12:00 AM PDT For patients with severe hypoxemia with pulmonary hypertension or right heart dysfunction, inhaled epoprostenol through high-flow nasal cannula increases oxygenation, according to a study published in Pharmaceutics . The researchers of this retrospective study assessed the effect of inhaled epoprostenol using a high-flow nasal cannula on oxygenation and future mechanical ventilation in patients with hypoxemia comorbid with pulmonary hypertension or right heart dysfunction in an intensive care unit setting. A chart review was completed on adult patients who were admitted into the respiratory care department of the Rush University Medical Center for severe hypoxemia between July 2015 and April 2018 and treated with inha...
Read more

Dyspnea (Shortness of Breath): Causes, Symptoms & Treatment - my.clevelandclinic.org

Image
Overview Shortness of breath (dyspnea) is most commonly caused by heart or lung conditions. Other causes include anemia, anxiety, lack of exercise or living with obesity. What is dyspnea (shortness of breath)? Dyspnea (pronounced "DISP-nee-uh") is the word healthcare providers use for feeling short of breath. You might describe it as not being able to get enough air ("air hunger"), chest tightness or working harder to breathe. Shortness of breath is often a symptom of heart and lung problems. But it can also be a sign of other conditions like asthma, allergies or anxiety. Intense exercise or having a cold can also make you feel breathless. What are paroxysmal nocturnal dyspnea (PND) and sighing dyspnea? Paroxysmal nocturnal dyspnea (PND) is a feeling like you can't breathe an hour or two after falling asleep. Sighing dyspnea is when you sigh a lot after taking deep breaths in to try to relieve the feeling of dyspnea. What is the differ...
Read more

What to Expect During Pulmonary Embolism Recovery - Healthline

Image
What to Expect During Pulmonary Embolism Recovery - Healthline What to Expect During Pulmonary Embolism Recovery - Healthline Pulmonary Arterial Hypertension: Updates in Epidemiology and Evaluation of Patients - AJMC.com Managed Markets Network Right-Sided Heart Failure: Symptoms, Causes, and Treatments - Healthline Right sided heart failure: Symptoms, outlook, treatment - Medical News Today What to Expect During Pulmonary Embolism Recovery - Healthline Posted: 19 May 2021 12:00 AM PDT A pulmonary embolism (PE) is when a blood clot becomes stuck in the blood vessels of your lung. These clots typically begin in the leg and then break free and travel to the lung. The American Lung Association estimates that about 1 in 1,000 people in the United States experience a PE each year. A PE can be a serious or life threatening condition, which means receiving prompt medical treatment is vital. Treatment of a PE focus...
Read more